Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal Status
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.High Gleason score and PSA levels predict prostate cancer recurrence after surgery. Preoperative hypogonadism did not correlate with increased biochemical recurrence within five years, suggesting cancer aggressiveness is a key factor.
Area Of Science
- Urology
- Oncology
- Endocrinology
Background
- Prostate cancer (PCa) treatment failure rates remain high, necessitating improved patient risk stratification.
- Identifying patients at risk for biochemical recurrence (BCR) is crucial for reducing PCa mortality.
Purpose Of The Study
- To evaluate the 5-year biochemical recurrence (BCR) rate in localized prostate cancer patients after radical prostatectomy.
- To assess the association between presurgery gonadal status and BCR following treatment.
Main Methods
- A prospective cohort study of 1318 patients undergoing radical prostatectomy for localized PCa with 5-year follow-up.
- Collection of baseline clinical, hormonal (total testosterone [TT], bioavailable testosterone [BT]), and metabolic syndrome data.
- Multivariate and Kaplan-Meier analyses to assess factors associated with BCR and BCR-free survival.
Main Results
- No association was found between preoperative hypogonadism (low TT and BT levels) and BCR within 5 years post-surgery.
- Higher Gleason score and elevated baseline prostate-specific antigen (PSA) levels were significantly correlated with increased BCR risk.
- Cancer aggressiveness (Gleason score, pT stage) and baseline PSA are key predictors of BCR.
Conclusions
- Prostate-specific antigen (PSA) levels, high Gleason score, and pT >3a stage are significant prognostic indicators for disease recurrence after initial treatment.
- Biochemical hypogonadism was not associated with a higher incidence of BCR within 5 years of prostatectomy.
- Preoperative gonadal status may inform therapeutic decisions but is not a primary indicator for oncological follow-up.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
